Clinical Trial Update: MRI for Screening and Monitoring Scleroderma ILD

View source ↗

Summary

An update on a clinical trial evaluating MRI for screening and monitoring interstitial lung disease in systemic sclerosis (scleroderma), sponsored by University…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis
• Systemic Sclerosis-associated Interstitial Lung Disease

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Scleroderma | Status: ACTIVE_NOT_RECRUITING